These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11801690)

  • 1. In situ beta cell death promotes priming of diabetogenic CD8 T lymphocytes.
    Zhang Y; O'Brien B; Trudeau J; Tan R; Santamaria P; Dutz JP
    J Immunol; 2002 Feb; 168(3):1466-72. PubMed ID: 11801690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-priming of diabetogenic T cells dissociated from CTL-induced shedding of beta cell autoantigens.
    Yamanouchi J; Verdaguer J; Han B; Amrani A; Serra P; Santamaria P
    J Immunol; 2003 Dec; 171(12):6900-9. PubMed ID: 14662897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
    Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B
    Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR9 blockade inhibits activation of diabetogenic CD8+ T cells and delays autoimmune diabetes.
    Zhang Y; Lee AS; Shameli A; Geng X; Finegood D; Santamaria P; Dutz JP
    J Immunol; 2010 May; 184(10):5645-53. PubMed ID: 20393135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different diabetogenic potential of autoaggressive CD8+ clones associated with IFN-gamma-inducible protein 10 (CXC chemokine ligand 10) production but not cytokine expression, cytolytic activity, or homing characteristics.
    Ejrnaes M; Videbaek N; Christen U; Cooke A; Michelsen BK; von Herrath M
    J Immunol; 2005 Mar; 174(5):2746-55. PubMed ID: 15728483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction.
    Chong MM; Chen Y; Darwiche R; Dudek NL; Irawaty W; Santamaria P; Allison J; Kay TW; Thomas HE
    J Immunol; 2004 May; 172(9):5714-21. PubMed ID: 15100317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo.
    Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P
    Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invariant NKT cells exacerbate type 1 diabetes induced by CD8 T cells.
    Griseri T; Beaudoin L; Novak J; Mars LT; Lepault F; Liblau R; Lehuen A
    J Immunol; 2005 Aug; 175(4):2091-101. PubMed ID: 16081775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8+ T cell tolerance in nonobese diabetic mice is restored by insulin-dependent diabetes resistance alleles.
    Martinez X; Kreuwel HT; Redmond WL; Trenney R; Hunter K; Rosen H; Sarvetnick N; Wicker LS; Sherman LA
    J Immunol; 2005 Aug; 175(3):1677-85. PubMed ID: 16034108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low dose streptozotocin-induced diabetes in rat insulin promoter-mCD80-transgenic mice is T cell autoantigen-specific and CD28 dependent.
    Pechhold K; Patterson NB; Blum C; Fleischacker CL; Boehm BO; Harlan DM
    J Immunol; 2001 Feb; 166(4):2531-9. PubMed ID: 11160314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice.
    Tian J; Zekzer D; Hanssen L; Lu Y; Olcott A; Kaufman DL
    J Immunol; 2001 Jul; 167(2):1081-9. PubMed ID: 11441119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perforin-independent beta-cell destruction by diabetogenic CD8(+) T lymphocytes in transgenic nonobese diabetic mice.
    Amrani A; Verdaguer J; Anderson B; Utsugi T; Bou S; Santamaria P
    J Clin Invest; 1999 Apr; 103(8):1201-9. PubMed ID: 10207172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymic and postthymic regulation of diabetogenic CD8 T cell development in TCR transgenic nonobese diabetic (NOD) mice.
    Kanagawa O; Shimizu J; Vaupel BA
    J Immunol; 2000 May; 164(10):5466-73. PubMed ID: 10799914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNF receptor 1-dependent beta cell toxicity as an effector pathway in autoimmune diabetes.
    Kägi D; Ho A; Odermatt B; Zakarian A; Ohashi PS; Mak TW
    J Immunol; 1999 Apr; 162(8):4598-605. PubMed ID: 10201999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An islet-specific CD8+ T cell hybridoma generated from non-obese diabetic mice recognizes insulin as an autoantigen.
    McInerney MF; Burkey J; Guan L; Flynn JC; Oravecz KI; Janeway CA
    Diabetes Res Clin Pract; 2000 Mar; 47(3):151-68. PubMed ID: 10741564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic lymph nodes are required for priming of beta cell reactive T cells in NOD mice.
    Gagnerault MC; Luan JJ; Lotton C; Lepault F
    J Exp Med; 2002 Aug; 196(3):369-77. PubMed ID: 12163565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
    Gallichan WS; Balasa B; Davies JD; Sarvetnick N
    J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in type 1 diabetes.
    Trembleau S; Penna G; Gregori S; Magistrelli G; Isacchi A; Adorini L
    J Immunol; 2000 Dec; 165(12):6748-55. PubMed ID: 11120794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotargeting of insulin reactive CD8 T cells to prevent diabetes.
    Scott GS; Fishman S; Khai Siew L; Margalit A; Chapman S; Chervonsky AV; Wen L; Gross G; Wong FS
    J Autoimmun; 2010 Dec; 35(4):390-7. PubMed ID: 20850948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-cell-cytotoxic CD8+ T cells from nonobese diabetic mice use highly homologous T cell receptor alpha-chain CDR3 sequences.
    Santamaria P; Utsugi T; Park BJ; Averill N; Kawazu S; Yoon JW
    J Immunol; 1995 Mar; 154(5):2494-503. PubMed ID: 7868915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.